Quick verdict
Embla is the better pick for most patients on overall scoring. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
That said, Calibrate wins on specific dimensions. Calibrate is a coaching and insurance-navigation program whose value proposition has weakened as direct-to-consumer pricing from Lilly and Novo undercut the 'we'll handle insurance for you' pitch. Cut its fee from $299 to $199 in 2026.
Side-by-side
| Calibrate | Embla | |
|---|---|---|
| Starts from | $199/mo (+ med separate) | $249/mo (+ med separate) |
| Lock-in | 3-month minimum | 12-month commitment |
| Time to prescription | 14 days | 7 days |
| Consultation type | Synchronous | Synchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Calibrate | Embla | |
|---|---|---|
| Pricing transparency | 5/10 | 6/10 |
| Cancellation terms | 6/10 | 7/10 |
| Onboarding experience | 4/10 | 6/10 |
| Medication options | 7/10 | 7/10 |
| Member outcomes | 3/10 | 8/10 |
When to choose Calibrate
Patients who specifically want behavioral coaching and have insurance that covers branded GLP-1s. Calibrate's clinicians and coaches handle prior authorization paperwork well.
When to choose Embla
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
FAQ
Is Calibrate cheaper than Embla?
Can I switch from Calibrate to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →